1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
BRN2 is a non-canonical melanoma tumor-suppressor
(
- Contribution to journal › Article
- 2017
-
Mark
KITD816V induces SRC-mediated tyrosine phosphorylation of MITF and altered transcription program in melanoma
(
- Contribution to journal › Article
- 2015
-
Mark
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.
(
- Contribution to journal › Article